Quick Answer
CorMedix Inc. reported Net Income Loss of $163.06 million for the year ending 2025.
- CorMedix Inc. showed an increase of +1,009.4% in Net Income Loss from 2024 to 2025.
- This data is from CorMedix Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2012: -$624.2 thousand | Q3 2012: -$1.03 million | Q1 2013: -$1.25 million | Q2 2013: -$1.95 million | Q3 2013: -$2.50 million | Q1 2014: -$16.71 million | Q2 2014: $3.51 million | Q3 2014: -$5.04 million | Q1 2015: -$5.5 thousand | Q2 2015: -$4.1 thousand | Q3 2015: -$4.7 thousand | Q4 2015: -$3.9 thousand | Q1 2016: -$4.12 million | Q2 2016: -$4.89 million | Q3 2016: -$9.13 million | Q4 2016: -$6.4 thousand | Q1 2017: -$7.60 million | Q2 2017: -$5.15 million | Q3 2017: -$9.96 million | Q1 2018: -$10.19 million | Q2 2018: -$8.56 million | Q3 2018: -$10.24 million | Q1 2019: -$5.17 million | Q2 2019: -$696.2 thousand | Q3 2019: -$5.26 million | Q1 2020: -$5.56 million | Q2 2020: -$3.78 million | Q3 2020: -$6.60 million | Q1 2021: -$7.22 million | Q2 2021: -$4.63 million | Q3 2021: -$8.57 million | Q1 2022: -$7.03 million | Q2 2022: -$7.60 million | Q3 2022: -$6.85 million | Q1 2023: -$10.57 million | Q2 2023: -$11.27 million | Q3 2023: -$9.74 million | Q1 2024: -$14.47 million | Q2 2024: -$14.15 million | Q3 2024: -$2.78 million | Q1 2025: $20.64 million | Q2 2025: $19.83 million | Q3 2025: $108.56 million.
- Over the full 19 years of available data (2007 to 2025), CorMedix Inc.'s Net Income Loss has grown by 2,352.9%.
- Historical annual values: Fiscal year 2025: $163.06 million | Fiscal year 2024: -$17.93 million | Fiscal year 2023: -$46.34 million | Fiscal year 2022: -$29.70 million | Fiscal year 2021: -$28.21 million | Fiscal year 2020: -$22.03 million | Fiscal year 2019: -$16.43 million | Fiscal year 2018: -$26.83 million | Fiscal year 2017: -$33.01 million | Fiscal year 2016: -$24.64 million | Fiscal year 2015: -$18.19 million | Fiscal year 2014: -$20.45 million | Fiscal year 2013: -$9.13 million | Fiscal year 2012: -$3.38 million | Fiscal year 2011: -$6.71 million | Fiscal year 2010: -$10.91 million | Fiscal year 2009: -$8.12 million | Fiscal year 2008: -$9.00 million | Fiscal year 2007: -$7.24 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: